SCHEMBL12622802

SCHEMBL12622802

CC(C)(C)C(=O)N1CCC(c2cc3ccccc3[nH]c2=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 1/20 0.50
CALCRL Q16602 10/20 0.47
AKR1C3 P42330 5/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
BRD4 O60885 1/20 0.44
POLB P06746 1/20 0.44
CREBBP Q92793 1/20 0.44
SMYD3 Q9H7B4 1/20 0.43
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 1/20 0.41
SLC9A1 P19634 1/20 0.41
CYP2C19 P33261 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23748832 0.85 KDM4E (0.52) RBP4CALCRLKDM4E
SCHEMBL5745535 0.85 RBP4 (0.51) RBP4CALCRLAKR1C3KDM4EALDH1A1
SCHEMBL29872305 0.84 RBP4 (0.50) RBP4CALCRLAKR1C3KDM4EALDH1A1
SCHEMBL13313599 0.81 HRH4 (0.49) RBP4CALCRLBRD4CYP3A4
SCHEMBL23564700 0.79 AKR1C3 (0.45) RBP4CALCRLAKR1C3CYP3A4
SCHEMBL27792401 0.79 DAO (0.53) KDM4EALDH1A1BRD4SMYD3CYP3A4
SCHEMBL14540181 0.78 BRD4 (0.44) RBP4CALCRLALDH1A1BRD4SMYD3
SCHEMBL13801368 0.77 BRD4 (0.43) RBP4CALCRLAKR1C3ALDH1A1BRD4
SCHEMBL677495 0.76 BRD4 (0.50) KDM4EALDH1A1BRD4SMYD3MEN1
SCHEMBL16801496 0.75 KDM4E (0.76) KDM4EALDH1A1BRD4POLBCREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947678-B2 Heterocyclic benzodiazepine CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-05-24 US disclosed
US-7947678-B2 Heterocyclic benzodiazepine CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-05-24 US disclosed
US-20090105228-A1 Heterocyclic benzodiazepine cgrp receptor antagonists MERCK SHARP & DOHME LLC 2009-04-23 US disclosed
US-20090105228-A1 Heterocyclic benzodiazepine cgrp receptor antagonists MERCK SHARP & DOHME LLC 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105228-A1 Heterocyclic benzodiazepine cgrp receptor antagonists BDKRB2, BDKRB1, CCKBR RBP4 3136/4885CALCRL 15/4885AKR1C3 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.